Patent Assignment
Reel/Frame 017706/0815
Security Agreement
Recorded: 2006-06-02
Pages: 13
Assignors
METAGENICS, INC.
Executed: 2005-05-31
METAGENICS FAR EAST, INC.
Executed: 2005-05-31
META PROTEOMICS, L.L.C.
Executed: 2006-05-31
Assignee
COMERICA BANK
333 SANTA CLARA AVE, SAN JOSE, CALIFORNIA, 95113
Covered Properties
(53)
Anabolic Mineral Formula
Patent:
5,164,384 →
Application:
07/717,550 →
Improved Endurance and Rehydration Composition
Patent:
5,270,297 →
Application:
07/919,355 →
Medical Food Composition for Metabolic Detoxification
Patent:
5,629,023 →
Application:
08/156,090 →
Ascorbic Acid Compositions Providing Enhanced Human Immune System Activity
Patent:
5,626,883 →
Application:
08/228,587 →
Bacteria and Immunoglobulin-Containing Composition for Human Gastrointestinal Health
Patent:
5,531,988 →
Application:
08/331,140 →
Immunoglobulin and Fiber-Containing Composition for Human Gastrointestinal Health
Patent:
5,531,989 →
Application:
08/437,316 →
Medical Food Composition for Metabolic Detoxification
Patent:
5,637,324 →
Application:
08/463,628 →
Immunoglobulin and Fiber-Containing Composition for Human Gastrointerstinal Health
Patent:
5,744,134 →
Application:
08/674,115 →
Medical Food Composition of Reduced Allergenicity Especially Adapted for Improving Gut Mucosal Integrity
Patent:
6,051,260 →
Application:
09/056,734 →
Immunoglobulin and Fiber-Containing Composition for Human Gastrointestinal Health
Patent:
6,180,099 →
Application:
09/062,204 →
Medical Food for Treating Inflammation-Related Diseases
Patent:
6,210,701 →
Application:
09/302,693 →
Dietary Supplements for Treating Fatigue-Related Syndromes
Patent:
6,352,712 →
Application:
09/303,779 →
Bacteria-And Fiber-Containing Composition for Human Gastrointestinal Health
Patent:
6,241,983 →
Application:
09/320,429 →
Compostion and Method for Treatment of Inflamation and Pain in Mammals
Patent:
6,534,086 →
Application:
09/519,527 →
Anti-inflammatory and connective tissue repair formulations
Application:
09/524,416 →
Composition for Promoting Healthy Bone Structure
Patent:
6,447,809 →
Application:
09/568,903 →
Composition and Method for Improved Carbohydrate Management in Mammals
Patent:
6,528,502 →
Application:
09/633,926 →
Dietary Supplements for Treating Inflammation-Related Diseases
Dietary Supplement Containing Glycerol Ester of Conjugated Linoleic Acid and Rosemary Extract Containing Carnosic Acid
Patent:
6,432,453 →
Application:
09/775,299 →
Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2
Combinations of sesquiterpene lactones and ditepene lactones or triterpenes for synergistic inhibition of cyclooxygenase-2
Application:
09/919,506 →
Publication:
US 2002/0076452
Novel Anti-Inflammatory Cyclooxygenase Inhibitors
Medical composition for managing hormone balance
Application:
10/056,858 →
Publication:
US 2002/0192310
Coating for orally administered compositions
Application:
10/062,749 →
Publication:
US 2003/0082231
Oral Composition with Insulin-Like Activities and Methods of Use
Curcuminoid Compositions Exhibiting Synergistic Inhibition of the Expression and/or Activity of Cyclooxygenase-2
Composition for Promoting Healthy Bone Structure
Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2
Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
Application:
10/282,236 →
Publication:
US 2003/0096027
Medical Composition for Balancing Bodily Processes
Application:
10/352,388 →
Publication:
US 2003/0190381
Method for Treatment of Inflammation and Pain in Mammals
Modulation of NF-kB by hops fractions and derivatives
Application:
10/400,293 →
Synergistic compositions that treat or inhibit pathological conditions associated with tissue-specific activation of NF-kB
Application:
10/401,283 →
Synergistic Compositions That Treat or Inhibit Pathological Conditions Associated with Inflammatory Response
Modulation of inflammation by hops fractions and derivatives
Application:
10/464,834 →
Publication:
US 2004/0115290
Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2
Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
Application:
10/484,123 →
Publication:
US 2004/0247700
Compositions That Treat or Inhibit Pathological Conditions Associated with Inflammatory Response
Medical composition for balancing bodily processes
Application:
10/735,526 →
Publication:
US 2004/0220118
Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
Application:
10/774,048 →
Publication:
US 2004/0219240
Synergistic anti-inflammatory pharmaceutical compositions and methods of use
Application:
10/789,814 →
Publication:
US 2005/0192356
Synergistic Anti-Inflammatory Pharmaceutical Compositions and Related Methods Using Curcuminoids or Methylxanthines
Encapsulated fractions isolated or derived from hops
Application:
10/846,948 →
Publication:
US 2009/0087512
Inhibition of Cox-2 and/or 5-Lox Activity by Fractions Isolated or Derived from Hops
Compositions exhibiting inhibition of cyclooxygenase-2
Application:
10/988,392 →
Medical food for managing hormone balance
Application:
60/265,908 →
Coating for orally administered compositions
Application:
60/266,269 →
Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
Application:
60/306,055 →
Arginine compositions for coordinate modification of multiple cardiovascular risk factors
Application:
60/316,685 →
Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
Application:
60/335,062 →
Medical composition for balancing bodily processes
Application:
60/352,016 →
Optimization of estrogenic hormone levels
Application:
60/432,689 →
Anti-inflammatory compositions containing hops fractions or derivatives exhibiting low gastrointestinal irritation
Application:
60/450,237 →
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 11, 2004
From: LIPOPROTEIN TECHNOLOGIES, INC.
To: METAPROTEOMICS, INC.
Reel/Frame 014421/0736 →
Assignment of Assignor's Interest
Dec 7, 2006
From: PHOENIX AG
To: PHOENIX DICHTUNGSTECHNIK GMBH
Reel/Frame 018654/0644 →
Assignment of Assignor's Interest
Nov 6, 2008
From: PAUL, STEPHEN M.
To: METAGENICS, INC.
Reel/Frame 021796/0275 →
Assignment of Assignor's Interest
Nov 6, 2008
From: PAUL, STEPHEN M.
To: METAGENICS, INC.
Reel/Frame 021796/0661 →
Assignment of Assignor's Interest
Nov 10, 2008
From: DARLAND, GARY K.; LUKACZER, DANIEL O.; LISKA, DEANN J.; IRVING, TRACEY A.
To: HEALTHCOMM INTERNATIONAL, INC.
Reel/Frame 021808/0887 →
Assignment of Assignor's Interest
Dec 31, 2008
From: ASHMEAD, H. DWAYNE
To: ALBION INTERNATIONAL, INC.
Reel/Frame 022043/0372 →
Assignment of Assignor's Interest
Dec 31, 2008
From: PAUL, STEPHEN M.
To: METAGENICS, INC.
Reel/Frame 022043/0369 →
Assignment of Assignor's Interest
Jan 27, 2009
From: ASHMEAD, H. DWAYNE
To: ALBION INTERNATIONAL, INC.
Reel/Frame 022162/0061 →
Security Agreement
Oct 15, 2009
From: METAGENICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 023373/0771 →
Security Agreement
Oct 15, 2009
From: META PROTEOMICS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 023373/0684 →
Release of Security Interest
Oct 26, 2009
From: COMERICA BANK
To: METAGENICS, INC.; METAGENICS FAR EAST, INC.; META PROTEOMICS, LLC
Reel/Frame 023419/0640 →
Release of Security Interest
Oct 26, 2009
From: COMERICA BANK
To: METAGENICS, INC.; METAGENICS FAR EAST, INC.; META PROTEOMICS, LLC
Reel/Frame 023424/0316 →
Release of Security Interest
Oct 26, 2009
From: COMERICA BANK
To: METAGENICS, INC.; METAGENICS FAR EAST, INC.; META PROTEOMICS, LLC
Reel/Frame 023419/0569 →
Release of Security Interest
Oct 26, 2009
From: COMERICA BANK
To: METAGENICS, INC.; METAGENICS FAR EAST, INC.; META PROTEOMICS, LLC
Reel/Frame 023419/0662 →
Release of Security Interest
Oct 26, 2009
From: COMERICA BANK
To: METAGENICS, INC.; METAGENICS FAR EAST, INC.; META PROTEOMICS, LLC
Reel/Frame 023419/0486 →
Release of Security Interest
Oct 25, 2021
From: BANK OF AMERICA, N.A.
To: META PROTEOMICS, LLC
Reel/Frame 057909/0199 →
Release of Security Interest
Oct 25, 2021
From: BANK OF AMERICA, N.A.
To: METAGENICS, INC.
Reel/Frame 057909/0315 →
Security Interest
Nov 1, 2021
From: METAGENICS, INC.; METAPROTEOMICS, LLC
To: FORTRESS CREDIT CORP., AS COLLATERAL AGENT
Reel/Frame 057981/0156 →
Security Interest
Nov 4, 2021
From: METAGENICS, INC.; METAPROTEOMICS, LLC
To: FORTRESS CREDIT CORP. (AS COLLATERAL AGENT)
Reel/Frame 058015/0602 →
Termination and Release of Patent Security Agreement - Reel/Frame 058015/0602
Dec 23, 2025
From: FORTRESS CREDIT CORP.
To: METAGENICS LLC (FKA METAGENICS, INC.); METAPROTEOMICS, LLC
Reel/Frame 074050/0670 →
Termination and Release of Patent Security Agreement - Reel/Frame 057981/0156
Dec 24, 2025
From: FORTRESS CREDIT CORP.
To: METAGENICS LLC (FKA METAGENICS, INC.); METAPROTEOMICS, LLC
Reel/Frame 074057/0392 →